News
BTMD
1.860
+3.91%
0.070
Weekly Report: what happened at BTMD last week (0406-0410)?
Weekly Report · 1d ago
Weekly Report: what happened at BTMD last week (0330-0403)?
Weekly Report · 04/06 10:30
Biote Updates April 2026 Investor Presentation on Growth
TipRanks · 04/03 20:30
Biote announces annual shareholder meeting notice and proxy materials release
Reuters · 04/02 20:13
Weekly Report: what happened at BTMD last week (0323-0327)?
Weekly Report · 03/30 10:31
Weekly Report: what happened at BTMD last week (0316-0320)?
Weekly Report · 03/23 10:27
Weekly Report: what happened at BTMD last week (0309-0313)?
Weekly Report · 03/16 10:26
Inventory Forecasting Woes: Biote Corp. Faces Material Risk From Demand Volatility and Stock Management Challenges
TipRanks · 03/15 06:01
Biote Corp. Earnings Call Maps Pain Now, Promise Later
TipRanks · 03/13 00:17
Biote Corporation Releases Transcript of Fourth Quarter and Full Year 2025 Earnings Conference Call
Reuters · 03/12 20:46
Biote Price Target Cut to $2.00/Share From $3.00 by B. Riley Securities
Dow Jones · 03/12 17:11
Biote Is Maintained at Neutral by B. Riley Securities
Dow Jones · 03/12 17:11
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $2
Benzinga · 03/12 17:01
Biote Price Target Cut to $2.50/Share From $3.00 by TD Cowen
Dow Jones · 03/12 16:58
Biote Is Maintained at Buy by TD Cowen
Dow Jones · 03/12 16:58
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2.5
Benzinga · 03/12 16:48
Biote price target lowered to $2 from $3 at B. Riley
TipRanks · 03/12 12:42
Biote price target lowered to $3 from $4.50 at Roth Capital
TipRanks · 03/12 12:42
Biote price target lowered to $2.50 from $3 at TD Cowen
TipRanks · 03/12 12:36
Roth MKM Reaffirms Their Buy Rating on biote (BTMD)
TipRanks · 03/12 12:17
More
Webull provides a variety of real-time BTMD stock news. You can receive the latest news about Biote through multiple platforms. This information may help you make smarter investment decisions.
About BTMD
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.